Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 * | 90.47M 112M | Sales 2024 * | 130M 162M | Capitalization | 215M 267M |
---|---|---|---|---|---|
Net income 2023 * | -92M -114M | Net income 2024 * | -40M -49.7M | EV / Sales 2023 * | 1.83 x |
Net cash position 2023 * | 49.23M 61.17M | Net cash position 2024 * | 15.51M 19.27M | EV / Sales 2024 * | 1.53 x |
P/E ratio 2023 * |
-2.36
x | P/E ratio 2024 * |
-5.59
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.97% | 22.19B | |
-16.16% | 21.33B | |
-7.26% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |